The use of atosiban and ritodrine in external cephalic version

12Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective. To compare the efficacy of atosiban and ritodrine as tocolytic agents for successful external cephalic version (ECV). Factors affecting the success of ECV, as well as maternal and perinatal outcomes are reviewed. Method. A retrospective review of women who underwent ECV with either atosiban (2004) or ritodrine (2002). Results. Atosiban and ritodrine were similarly effective (28 versus 41%, p>0.05). Side effects were more common with ritodrine. No significant adverse maternal and perinatal outcomes were recorded following procedures with either tocolytic. Conclusion. Atosiban is a safe choice for ECV with less maternal side effects. However, it is no more effective than ritodrine and the benefit of safety has to be balanced against that of cost. © 2007 Taylor & Francis.

Cite

CITATION STYLE

APA

Stergiotou, I., Talbot, F., & Yoong, W. (2007). The use of atosiban and ritodrine in external cephalic version. Acta Obstetricia et Gynecologica Scandinavica, 86(8), 927–929. https://doi.org/10.1080/00016340701343123

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free